MPZL3 can initiate a cascade of intracellular events leading to the protein's functional activation through various pathways. Phorbol 12-myristate 13-acetate (PMA) and 12-O-Tetradecanoylphorbol-13-acetate (TPA) are both known to directly activate protein kinase C (PKC), which plays a significant role in the phosphorylation of MPZL3. This phosphorylation activates MPZL3, enabling it to perform its functions within the cell. Similarly, Forskolin raises the levels of cyclic AMP (cAMP) within the cell, which then activates protein kinase A (PKA). PKA can phosphorylate MPZL3, leading to an increase in its activity. Isoproterenol, by acting as a beta-adrenergic agonist, also elevates intracellular cAMP levels and activates PKA, which then phosphorylates and activates MPZL3. Another chemical, Ionomycin, increases intracellular calcium concentrations, which indirectly leads to the activation of calcineurin. Calcineurin can activate MPZL3 by dephosphorylating inhibitory phosphates on proteins that interact with MPZL3.
The activation of MPZL3 can also be influenced by growth factors and signaling molecules such as Epidermal Growth Factor (EGF), which binds to its receptor, resulting in a signaling cascade that can activate the MAPK/ERK pathway. This pathway can lead to the phosphorylation and consequent activation of MPZL3. Retinoic acid, which affects cell differentiation, can also lead to the activation of kinases that phosphorylate MPZL3. Anisomycin activates the JNK pathway, which phosphorylates transcription factors that increase the production of proteins that interact with and activate MPZL3. Dibutyryl-cAMP (db-cAMP), a cAMP analog, similarly activates PKA leading to the phosphorylation of MPZL3. Insulin, through its receptor, can stimulate the PI3K/Akt pathway and contribute to the activation of MPZL3. Lastly, Calyculin A, as a phosphatase inhibitor, ensures that MPZL3 remains phosphorylated by preventing dephosphorylation, maintaining the protein in an active state. These chemicals, by targeting specific signaling pathways and processes within the cell, all play a role in the activation of MPZL3 through direct or indirect mechanisms that involve phosphorylation events or the inhibition of dephosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is known to activate protein kinase C (PKC), which can lead to the phosphorylation of MPZL3, resulting in its functional activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn can activate PKA. PKA can phosphorylate MPZL3, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcineurin. Activated calcineurin can dephosphorylate proteins that, when phosphorylated, inhibit MPZL3, thus leading to its activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP levels, potentially leading to PKA activation and subsequent phosphorylation and activation of MPZL3. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $46.00 $249.00 | 2 | |
DiC8 is a synthetic diacylglycerol (DAG) analog that activates PKC; PKC can then phosphorylate MPZL3, leading to its functional activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is a JNK activator; JNK activation can lead to the phosphorylation of transcription factors that increase the production of proteins that interact with and activate MPZL3. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid can influence cell differentiation and may lead to the activation of signaling pathways that include kinases which phosphorylate and activate MPZL3. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can phosphorylate MPZL3, leading to its activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin binds to its receptor, stimulating the PI3K/Akt pathway, which can lead to the phosphorylation and activation of downstream proteins including MPZL3. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A is a phosphatase inhibitor that prevents the dephosphorylation of proteins, potentially maintaining MPZL3 in an activated phosphorylated state. | ||||||